These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Oral etoposide in gestational trophoblastic disease.
    Author: Wong LC, Choo YC, Ma HK.
    Journal: Cancer Treat Rep; 1984 May; 68(5):775-7. PubMed ID: 6327035.
    Abstract:
    Ten patients with persistent or metastatic trophoblastic disease following molar pregnancy were treated with etoposide orally, administered on an outpatient basis. All patients achieved sustained biochemical remission. The mean duration of treatment was 8 weeks. The side effects were mild. The use of etoposide in patients resistant to conventional chemotherapy is discussed.
    [Abstract] [Full Text] [Related] [New Search]